VAERS reports by lot

Moderna COVID-19 lot 012L2OA: VAERS reports

37 VAERS reports list lot 012L2OA as a Moderna COVID-19 vaccine, received between 2021-01-08 and 2022-09-30. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
37
Reports
11%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3922%
Injection-site / Local reaction2615%
Dermatological (non-injection-site)2313%
Cardiac / Cardiovascular2011%
Neurological1710%
Musculoskeletal1710%
Respiratory116%
Allergic / Anaphylactic95%
Gastrointestinal95%
Thrombotic / Hematological21%
Psychiatric / Neuropsychiatric11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York8
Pennsylvania6
Massachusetts4
Ohio2
Florida2
North Carolina2
Connecticut1
Oklahoma1
New Jersey1
Illinois1
Georgia1
Michigan1

Reports by month received

2021-0125
2021-024
2021-032
2021-083
2021-091
2021-121
2022-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.